Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Martin Witzenrath and Leif Sander.
Connection Strength

1.295
  1. Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19. Nat Commun. 2021 08 11; 12(1):4869.
    View in: PubMed
    Score: 0.240
  2. Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19). Infection. 2020 Aug; 48(4):619-626.
    View in: PubMed
    Score: 0.222
  3. Heart failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findings. Eur J Heart Fail. 2021 11; 23(11):1891-1902.
    View in: PubMed
    Score: 0.060
  4. Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study. Clin Microbiol Infect. 2021 Oct; 27(10):1520.e7-1520.e10.
    View in: PubMed
    Score: 0.059
  5. A time-resolved proteomic and prognostic map of COVID-19. Cell Syst. 2021 08 18; 12(8):780-794.e7.
    View in: PubMed
    Score: 0.059
  6. Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study. Infection. 2021 Aug; 49(4):703-714.
    View in: PubMed
    Score: 0.059
  7. CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity. Infection. 2021 Aug; 49(4):757-762.
    View in: PubMed
    Score: 0.059
  8. Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses. Front Immunol. 2020; 11:628971.
    View in: PubMed
    Score: 0.058
  9. Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19. Nat Biotechnol. 2021 06; 39(6):705-716.
    View in: PubMed
    Score: 0.058
  10. A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model. Cell. 2020 11 12; 183(4):1058-1069.e19.
    View in: PubMed
    Score: 0.057
  11. Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment. Cell. 2020 09 17; 182(6):1419-1440.e23.
    View in: PubMed
    Score: 0.056
  12. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature. 2020 11; 587(7833):270-274.
    View in: PubMed
    Score: 0.056
  13. COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis. Nat Biotechnol. 2020 08; 38(8):970-979.
    View in: PubMed
    Score: 0.056
  14. Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection. Cell Syst. 2020 07 22; 11(1):11-24.e4.
    View in: PubMed
    Score: 0.055
  15. Antibiotic treatment-induced secondary IgA deficiency enhances susceptibility to Pseudomonas aeruginosa pneumonia. J Clin Invest. 2018 08 01; 128(8):3535-3545.
    View in: PubMed
    Score: 0.049
  16. The cGAS/STING Pathway Detects Streptococcus pneumoniae but Appears Dispensable for Antipneumococcal Defense in Mice and Humans. Infect Immun. 2018 03; 86(3).
    View in: PubMed
    Score: 0.047
  17. Spectrum of pathogen- and model-specific histopathologies in mouse models of acute pneumonia. PLoS One. 2017; 12(11):e0188251.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.